Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
Clinical trial NCT02563327 · COMPLETED
Trial details
- NCT number
- NCT02563327
- Sponsor
- Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-30
- Primary completion
- 2021-08-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.